Vision Plasma Systems, Inc. (VLNX: OTC Link) | Vision Plasma Systems names Dr. George McClane to Senior Advisory Board


Vision Plasma Systems names Dr. George McClane to Senior Advisory Board

Jun 25, 2012

OTC Disclosure News Service

Reno, CA –

NEWS RELEASE                                                        CONTACT: Media Relations

June 25, 2012                                                                                                                                                                             




Vision Plasma Systems, Inc. appoints Dr. George E. McClane as Advisor for Medical Sciences for Senior Advisory Board



Reno, NV. – Vision Plasma Systems, Inc. today announced the appointment of Dr. George E. McClane, M.D. as advisor for Medical Sciences on the Senior Advisory Board.  Dr. McClane is a key contributor to the Vision Plasma Systems team in the area of medical hazardous waste for handling, personnel quality of life, environmental safety and the overall medical and pharmaceutical industry best practices within federal and state rules and regulations.


Recently honored with the annual “10 de Dezembro Medal” from the Office of the Mayor, Londrina, Paraná, Brazil 2011, for his years of dedicated service to the City of Londrina, Dr. McClane is globally recognized for his expertise in medical sciences, as his professional work includes psychology, doctor of medicine, emergency room  chief resident and forensic medical evaluations.    He has 8 publications on intimate partner violence injuries.   Dr. McClane serves as an advisor to the US FBI, Scotland Yard, Interpol and Crown Prosecution of Canada. 


About Vision Plasma Systems, Inc.

Vision Plasma Systems, Inc. is a designer, developer, and marketer of its proprietary mobile plasma arc gasification unit called the Arc Master I.  The company is committed to providing affordable energy resource management for federal and commercial clients through sustainable and renewable energy technologies, land reclamation, products and services.


Safe Harbor

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.The words or phrases “would be,” “would allow,” “intends to'” “will likely result,” “are expected to,” “will continue,” “anticipate,” “expect,” “estimate,” “project,” “indicate,” “could,” “potentially,” “should,” “believe,” “considers,” or similar expressions are intended to identify “forward-looking statements.” Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company’s historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company’s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.




The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply